Cargando…

Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease

BACKGROUND: Intestinal macrophages are key immune cells in the maintenance of intestinal immune homeostasis and have a role in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms by which macrophages exert a pathological influence in both ulcerative colitis (UC) and Crohn d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dharmasiri, Suranga, Garrido-Martin, Eva M, Harris, Richard J, Bateman, Adrian C, Collins, Jane E, Cummings, J R Fraser, Sanchez-Elsner, Tilman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522792/
https://www.ncbi.nlm.nih.gov/pubmed/33570153
http://dx.doi.org/10.1093/ibd/izab029
_version_ 1784585156956258304
author Dharmasiri, Suranga
Garrido-Martin, Eva M
Harris, Richard J
Bateman, Adrian C
Collins, Jane E
Cummings, J R Fraser
Sanchez-Elsner, Tilman
author_facet Dharmasiri, Suranga
Garrido-Martin, Eva M
Harris, Richard J
Bateman, Adrian C
Collins, Jane E
Cummings, J R Fraser
Sanchez-Elsner, Tilman
author_sort Dharmasiri, Suranga
collection PubMed
description BACKGROUND: Intestinal macrophages are key immune cells in the maintenance of intestinal immune homeostasis and have a role in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms by which macrophages exert a pathological influence in both ulcerative colitis (UC) and Crohn disease (CD) are not yet well understood. METHODS: We purified intestinal macrophages from gastrointestinal mucosal biopsies (patients with UC, patients with CD, and healthy donors) and analyzed their transcriptome by RNA sequencing and bioinformatics, confirming results with quantitative polymerase chain reaction and immunohistochemistry. RESULTS: Compared with those of healthy donors, intestinal macrophages in patients with UC and with CD showed cellular reprograming of 1287 and 840 dysregulated genes, respectively (false discovery rate ≤ 0.1). The UC and CD intestinal macrophages showed an activated M1 inflammatory phenotype and the downregulation of genes engaged in drug/xenobiotic metabolism. Only macrophages from CD showed, concomitant to an M1 phenotype, a significant enrichment in the expression of M2 and fibrotic and granuloma-related genes. For the first time, we showed (and validated by quantitative polymerase chain reaction and immunohistochemistry) that intestinal macrophages in patients with IBD present both M1 and M2 features, as recently described for tumor-associated macrophages, that affect key pathways for IBD pathology, represented by key markers such as MMP12 (fibrosis), CXCL9 (T-cell attraction), and CD40 (T-cell activation). CONCLUSIONS: Our data support the therapeutic targeting of macrophages to maintain remission in IBD but also indicate that a shift toward an M2 program—as proposed by some reports—may not limit the recruitment and activation of T cells because M2 features do not preclude M1 activation in patients with UC or CD and could exacerbate M2-related CD-specific features such as fibrosis and the formation of granulomas.
format Online
Article
Text
id pubmed-8522792
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85227922021-10-19 Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease Dharmasiri, Suranga Garrido-Martin, Eva M Harris, Richard J Bateman, Adrian C Collins, Jane E Cummings, J R Fraser Sanchez-Elsner, Tilman Inflamm Bowel Dis Basic Science Research BACKGROUND: Intestinal macrophages are key immune cells in the maintenance of intestinal immune homeostasis and have a role in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms by which macrophages exert a pathological influence in both ulcerative colitis (UC) and Crohn disease (CD) are not yet well understood. METHODS: We purified intestinal macrophages from gastrointestinal mucosal biopsies (patients with UC, patients with CD, and healthy donors) and analyzed their transcriptome by RNA sequencing and bioinformatics, confirming results with quantitative polymerase chain reaction and immunohistochemistry. RESULTS: Compared with those of healthy donors, intestinal macrophages in patients with UC and with CD showed cellular reprograming of 1287 and 840 dysregulated genes, respectively (false discovery rate ≤ 0.1). The UC and CD intestinal macrophages showed an activated M1 inflammatory phenotype and the downregulation of genes engaged in drug/xenobiotic metabolism. Only macrophages from CD showed, concomitant to an M1 phenotype, a significant enrichment in the expression of M2 and fibrotic and granuloma-related genes. For the first time, we showed (and validated by quantitative polymerase chain reaction and immunohistochemistry) that intestinal macrophages in patients with IBD present both M1 and M2 features, as recently described for tumor-associated macrophages, that affect key pathways for IBD pathology, represented by key markers such as MMP12 (fibrosis), CXCL9 (T-cell attraction), and CD40 (T-cell activation). CONCLUSIONS: Our data support the therapeutic targeting of macrophages to maintain remission in IBD but also indicate that a shift toward an M2 program—as proposed by some reports—may not limit the recruitment and activation of T cells because M2 features do not preclude M1 activation in patients with UC or CD and could exacerbate M2-related CD-specific features such as fibrosis and the formation of granulomas. Oxford University Press 2021-02-11 /pmc/articles/PMC8522792/ /pubmed/33570153 http://dx.doi.org/10.1093/ibd/izab029 Text en © 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Basic Science Research
Dharmasiri, Suranga
Garrido-Martin, Eva M
Harris, Richard J
Bateman, Adrian C
Collins, Jane E
Cummings, J R Fraser
Sanchez-Elsner, Tilman
Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
title Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
title_full Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
title_fullStr Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
title_full_unstemmed Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
title_short Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
title_sort human intestinal macrophages are involved in the pathology of both ulcerative colitis and crohn disease
topic Basic Science Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522792/
https://www.ncbi.nlm.nih.gov/pubmed/33570153
http://dx.doi.org/10.1093/ibd/izab029
work_keys_str_mv AT dharmasirisuranga humanintestinalmacrophagesareinvolvedinthepathologyofbothulcerativecolitisandcrohndisease
AT garridomartinevam humanintestinalmacrophagesareinvolvedinthepathologyofbothulcerativecolitisandcrohndisease
AT harrisrichardj humanintestinalmacrophagesareinvolvedinthepathologyofbothulcerativecolitisandcrohndisease
AT batemanadrianc humanintestinalmacrophagesareinvolvedinthepathologyofbothulcerativecolitisandcrohndisease
AT collinsjanee humanintestinalmacrophagesareinvolvedinthepathologyofbothulcerativecolitisandcrohndisease
AT cummingsjrfraser humanintestinalmacrophagesareinvolvedinthepathologyofbothulcerativecolitisandcrohndisease
AT sanchezelsnertilman humanintestinalmacrophagesareinvolvedinthepathologyofbothulcerativecolitisandcrohndisease